DK3292867T3 - Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion - Google Patents

Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion Download PDF

Info

Publication number
DK3292867T3
DK3292867T3 DK16188201.4T DK16188201T DK3292867T3 DK 3292867 T3 DK3292867 T3 DK 3292867T3 DK 16188201 T DK16188201 T DK 16188201T DK 3292867 T3 DK3292867 T3 DK 3292867T3
Authority
DK
Denmark
Prior art keywords
triazol
prevention
treatment
bacterial infection
pyrimidine derivatives
Prior art date
Application number
DK16188201.4T
Other languages
English (en)
Inventor
Cécile Oury
Patrizio Lancellotti
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Application granted granted Critical
Publication of DK3292867T3 publication Critical patent/DK3292867T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK16188201.4T 2016-09-09 2016-09-09 Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion DK3292867T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16188201.4A EP3292867B1 (en) 2016-09-09 2016-09-09 Triazolo(4,5-d)pyrimidine derivatives for use in the prevention and treatment of bacterial infection

Publications (1)

Publication Number Publication Date
DK3292867T3 true DK3292867T3 (da) 2019-07-22

Family

ID=56896425

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16188201.4T DK3292867T3 (da) 2016-09-09 2016-09-09 Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion
DK17743050.1T DK3509598T3 (da) 2016-09-09 2017-07-25 Ny anvendelse af triazolo(4,5-d)pyrimidinderivater til forebyggelse og behandling af bakteriel infektion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17743050.1T DK3509598T3 (da) 2016-09-09 2017-07-25 Ny anvendelse af triazolo(4,5-d)pyrimidinderivater til forebyggelse og behandling af bakteriel infektion

Country Status (10)

Country Link
US (1) US20190194213A1 (da)
EP (2) EP3292867B1 (da)
JP (1) JP7075667B2 (da)
KR (1) KR102401152B1 (da)
CN (1) CN109689061B (da)
AU (1) AU2017324655B2 (da)
CA (1) CA3035686C (da)
DK (2) DK3292867T3 (da)
ES (2) ES2731658T3 (da)
WO (1) WO2018046174A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3527571A1 (en) 2018-02-14 2019-08-21 Université de Liège Pyrimidine derivatives for prevention and treatment of bacterial infection
JP7588859B2 (ja) * 2019-04-18 2024-11-25 ユニベルシテ・ド・リエージュ グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体
GB201910656D0 (en) * 2019-07-25 2019-09-11 Univ Liege New use of triazolo(4,5-d)Pyrimidine deerivatives
JP7737213B2 (ja) 2021-02-26 2025-09-10 ユニベルシテ・ド・リエージュ 新規の抗菌かつ抗血栓性の医療機器
WO2023213198A1 (zh) * 2022-05-04 2023-11-09 华东师范大学 芳香稠环化合物作为trek-1激活剂的用途、包含其的药物组合物、镇痛剂
EP4289435A1 (en) 2022-06-07 2023-12-13 Université de Liège N-alkyl-2-substituted atp analogues for use as antibacterial agent
CN120813359A (zh) 2023-03-13 2025-10-17 海罗利斯发展公司 用于治疗革兰氏阳性菌血症的替格瑞洛iv配制物
CN121910000A (zh) * 2023-08-17 2026-04-24 赛姆4治疗股份有限公司 新型高效抗菌组合物
WO2025108980A1 (en) * 2023-11-22 2025-05-30 Hyloris Developments Sa Intravenous administration of ticagrelor compositions in a patient who was previously administered an opioid in order to treat coagulation and avoid reduced ticagrelor uptake

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
WO2009034386A1 (en) * 2007-09-13 2009-03-19 Astrazeneca Ab Derivatives of adenine and 8-aza-adenine and uses thereof-796
WO2011017108A2 (en) * 2009-07-27 2011-02-10 Auspex Pharmaceuticals, Inc. Cyclopropyl modulators of p2y12 receptor
CN102770434A (zh) * 2009-12-03 2012-11-07 阿斯利康(瑞典)有限公司 三唑并[4,5-d]嘧啶血小板聚集抑制剂的共晶体
EP2714047A1 (en) * 2011-06-01 2014-04-09 AstraZeneca AB Novel ticagrelor co - crystal
CA2859580A1 (en) * 2011-12-23 2013-06-27 Lek Pharmaceuticals D.D. Synthesis of triazolopyrimidine compounds
US9233966B2 (en) * 2012-04-05 2016-01-12 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
WO2014000719A1 (en) * 2012-06-29 2014-01-03 Zentiva, K.S. Novel pharmaceutical solid forms of (1s,2s,3r,5s)-3-[7-[(1r,2s)-2-(3,4difluorophenyl)cyclopropylamino]-5-(propylthio)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-3yl]-5-(2-hydroxyethoxy)cyclopentane-l,2-diol
EP2870155B1 (en) * 2012-07-04 2016-08-24 LEK Pharmaceuticals d.d. Ticagrelor adducts with divalent metal salts
CN104341423B (zh) * 2013-08-02 2017-03-01 上海京新生物医药有限公司 替格瑞洛的一水合物及其制备方法与在制药中的应用
WO2015162537A1 (en) * 2014-04-23 2015-10-29 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Process for preparation of ticagrelor
WO2016116942A1 (en) * 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin

Also Published As

Publication number Publication date
ES2731658T3 (es) 2019-11-18
CA3035686C (en) 2023-07-25
EP3509598A1 (en) 2019-07-17
KR20190045237A (ko) 2019-05-02
EP3292867A1 (en) 2018-03-14
NZ751185A (en) 2023-10-27
EP3509598B1 (en) 2020-10-07
CN109689061A (zh) 2019-04-26
JP2019529398A (ja) 2019-10-17
BR112019003661A2 (pt) 2019-05-21
ES2841742T3 (es) 2021-07-09
DK3509598T3 (da) 2020-12-21
US20190194213A1 (en) 2019-06-27
JP7075667B2 (ja) 2022-05-26
CA3035686A1 (en) 2018-03-15
WO2018046174A1 (en) 2018-03-15
CN109689061B (zh) 2023-03-31
AU2017324655B2 (en) 2021-04-29
EP3292867B1 (en) 2019-05-15
KR102401152B1 (ko) 2022-05-24
AU2017324655A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
DK3230298T3 (da) 3-substituerede 5-amino-6H-thiazolo[4,5-d]pyrimidin-2,7-dion forbindelser til behandling og forebyggelse af virusinfektion
DK3509598T3 (da) Ny anvendelse af triazolo(4,5-d)pyrimidinderivater til forebyggelse og behandling af bakteriel infektion
LT3902803T (lt) Aza-heterobicikliniai mat2a inhibitoriai ir būdai, skirti panaudoti vėžio gydymui
DK3215511T3 (da) Substituerede pyrazolo(1,5-a)pyrimidiner og deres anvendelse i behandlingen af medicinske lidelser
DK3697405T3 (da) Ny mek-inhibitor til behandlingen af virale og bakterielle infektioner
WO2016109689A3 (en) Derivatives and methods of treating hepatitis b infections
PH12016501379A1 (en) Azepane derivatives and methods of treating hepatitis b infections
EP3495400A4 (en) BLOCK COPOLYMERS AND SURFACE TREATMENTS THEREFOR
ZA201706348B (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
LT3261642T (lt) Chinolino dariniai, skirti naudoti virusinės infekcijos gydymui arba prevencijai
IL268210A (en) Use of gaboxadol in the treatment of tinnitus
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
DK3519411T3 (da) Heterocykliske forbindelser og deres anvendelse inden for forebyggelsen eller behandlingen af bakterieinfektioner
HUE059149T2 (hu) 2,4-Diaminokinazolin származékok és azok alkalmazása vírusfertõzések, rák vagy allergiák kezelésében
LT3630111T (lt) Junginiai ir būdai, skirti bakterinių infekcijų gydymui
DK3752506T3 (da) Pyrimidinderivater til forebyggelse og behandling af bakterielle infektioner
LT3668856T (lt) Nauji tetrazolo junginiai ir jų panaudojimas gydant tuberkuliozę
DK3476397T3 (da) Nye sammensætninger og deres anvendelse til behandling af bakterielle infektioner
ZA201904998B (en) Novel heterocyclic compounds and their use in preventing or treating bacterial infections
WO2016073652A8 (en) Iminosugars useful for the treatment of viral diseases
EP3538094A4 (en) FORMULATIONS, METHODS, KIT AND PHARMACEUTICAL FORMS FOR TREATING BACTERIAL INFECTIONS
IL253418A0 (en) Nisin-based compounds and their use in the treatment of bacterial infections
HUE054772T2 (hu) Pirimidinszármazékok és alkalmazásuk respiratorikus szinciciális vírusfertõzés kezelésében vagy megelõzésében
HK1240214A1 (en) Derivatives and methods of treating hepatitis b infections